These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3672505)

  • 21. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure responses to phenylephrine infusions in subjects with Cushing's syndrome.
    McKnight JA; Rooney DP; Whitehead H; Atkinson AB
    J Hum Hypertens; 1995 Oct; 9(10):855-8. PubMed ID: 8576903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of surgical treatment on hypertension in Cushing's syndrome.
    Fallo F; Sonino N; Barzon L; Pistorello M; Pagotto U; Paoletta A; Boscaro M
    Am J Hypertens; 1996 Jan; 9(1):77-80. PubMed ID: 8834710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure.
    Toja PM; Branzi G; Ciambellotti F; Radaelli P; De Martin M; Lonati LM; Scacchi M; Parati G; Cavagnini F; Pecori Giraldi F
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):332-8. PubMed ID: 21854405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian variation of blood pressure and heart rate in normotensives, white-coat, masked, treated and untreated hypertensives.
    Koroboki E; Manios E; Psaltopoulou T; Vemmos K; Michas F; Alexaki E; Zakopoulos N
    Hellenic J Cardiol; 2012; 53(6):432-8. PubMed ID: 23178426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 24-h cortisol secretory pattern in Cushing's syndrome.
    Tourniaire J; Chalendar D; Rebattu B; Fevre-Montange M; Bajard L; Mazenod B; Dechaud H; Abou Samra AB; van Cauter E
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):230-7. PubMed ID: 3017037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dawn hypertension in pre-Cushing's syndrome: report of two cases].
    Hayashi T; Yamauchi A; Hosoda K; Kakehi R
    Hinyokika Kiyo; 1994 Jul; 40(7):597-600. PubMed ID: 8085520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-clinical Cushing's syndrome with body weight loss and normal circadian rhythm of blood pressure.
    Iwami T; Nakamura T; Niwamae N; Yamagishi T; Utsugi T; Nagai R
    Intern Med; 1998 Jun; 37(6):528-33. PubMed ID: 9678687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.
    Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Nihei M; Sekino H; Yoshinaga K
    J Hypertens; 1989 Feb; 7(2):113-20. PubMed ID: 2926131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.
    Cunningham JM; Buxton OM; Weiss RE
    J Endocrinol Invest; 2002 Oct; 25(9):791-9. PubMed ID: 12398238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenetic aspects of hypertension in Cushing's syndrome.
    Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H
    Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of arterial hypertension in Cushing's syndrome].
    Rodrigues D; Barros L; Ruas L; Gomes L; Geraldes E; Ruas MC
    Acta Med Port; 1997 Nov; 10(11):785-7. PubMed ID: 9549109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril in Cushing's syndrome.
    Greminger P; Vetter W; Groth H; Lüscher T; Tenschert W; Siegenthaler W; Vetter H
    Klin Wochenschr; 1984 Sep; 62(18):855-8. PubMed ID: 6387264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic significance of absent nocturnal blood pressure decrease in 24-hour long-term blood pressure measurement].
    Schrader J; Schoel G; Lüders S; Ruschitzka F; Warneke G; Scheler F
    Z Kardiol; 1992; 81 Suppl 2():83-6. PubMed ID: 1514320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.
    Avenatti E; Rebellato A; Iannaccone A; Battocchio M; Dassie F; Veglio F; Milan A; Fallo F
    Endocrine; 2017 Feb; 55(2):547-554. PubMed ID: 27179657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular structural characteristics in Cushing's syndrome.
    Fallo F; Budano S; Sonino N; Muiesan ML; Agabiti-Rosei E; Boscaro M
    J Hum Hypertens; 1994 Jul; 8(7):509-13. PubMed ID: 7932514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disproportionate hypertrophy of the interventricular septum and its regression in Cushing's syndrome. Report of three cases.
    Sugihara N; Shimizu M; Shimizu K; Ino H; Miyamori I; Nakabayashi H; Takeda R
    Intern Med; 1992 Mar; 31(3):407-13. PubMed ID: 1535248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.